
NextCure, Inc.
NXTC
|
NASDAQ
|
0 Urmăritori
Company Quality
Profitability Score
9/100
Solvency Score
50/100
Dividends
Dividends data currently unavailable.Earnings
8/7/2025
in 46 days
-
Revenue est.
-0.39
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industrie
Mr. Michael S. Richman MSBA
CEO
43
Angajați
Beltsville
Sediu
US
Țară
Key Metrics TTM
Valuation
Market cap.
$13MEnterprise Value
-$3.7MPrice to Earnings
-0.27Price to Sales
0.00Price to Book
0.24Price to Cash Flow
-0.32Profitability
Return on Assets
-73.76%Return on Equity
-70.16%Return on Invested Capital
-86.43%Gross Margin
0.00%Operating Margin
0.00%Net Margin
0.00%Liquidity
Quick Ratio
10.26Current Ratio
10.26Cash Ratio
3.80Inventory Turnover
0.00Asset Turnover
0.00Total Liabilities
$11MSolvency
Debt to Assets
0.07Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
0.83Long-term Debt to Cap.
0.00Altman Z-Score
-9.05Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.